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the type Vii secretion system 
protects Staphylococcus aureus 
against antimicrobial host fatty 
acids
Arnaud Kengmo tchoupa1, Kate e. Watkins1, Rebekah A. Jones1, Agnès Kuroki2, 
Mohammad tauqeer Alam1, Sebastien perrier1,2,3, Yin chen4 & Meera Unnikrishnan1*
the Staphylococcus aureus type VII secretion system (T7SS) exports several proteins that are pivotal 
for bacterial virulence. The mechanisms underlying T7SS-mediated staphylococcal survival during 
infection nevertheless remain unclear. Here we report that S. aureus lacking T7SS components are 
more susceptible to host-derived antimicrobial fatty acids. Unsaturated fatty acids such as linoleic acid 
(LA) elicited an increased inhibition of S. aureus mutants lacking T7SS effectors EsxC, EsxA and EsxB, 
or the membrane-bound ATPase EssC, compared to the wild-type (WT). T7SS mutants generated 
in different S. aureus strain backgrounds also displayed an increased sensitivity to LA. Analysis of 
bacterial membrane lipid profiles revealed that the esxC mutant was less able to incorporate LA into 
its membrane phospholipids. Although the ability to bind labelled LA did not differ between the WT 
and mutant strains, LA induced more cell membrane damage in the T7SS mutants compared to the 
WT. Furthermore, proteomic analyses of WT and mutant cell fractions revealed that, in addition 
to compromising membranes, T7SS defects induce oxidative stress and hamper their response to 
LA challenge. Thus, our findings indicate that T7SS contribute to maintaining S. aureus membrane 
integrity and homeostasis when bacteria encounter antimicrobial fatty acids.
Staphylococcus aureus is a facultative pathogen that can colonize the skin and nares of healthy individuals. The 
asymptomatic carriage of S. aureus is a major risk for subsequent  infections1. S. aureus infections, which can be 
healthcare or community-associated, range from benign impetigo to life-threatening  bacteraemia2. Clinical man-
agement of staphylococcal infections is complicated by the increasing prevalence of multidrug resistant  strains3.
The success of S. aureus as a deadly pathogen is attributed to an array of virulence factors that facilitate host 
tissue adhesion and immune response  evasion4. One of these virulence factors is the type VII secretion system 
(T7SS), also known as the ESAT-6 secretion system (ESS). The orthologous ESX-1 system was initially discovered 
in Mycobacterium tuberculosis, where it is essential for bacterial  virulence5. T7SSs (T7SSb) are found in both 
Gram-positive and Gram-negative bacteria, although these systems and their secretion machineries appear to 
be distinct to their mycobacterial  counterparts6. In S. aureus, the T7SS displays modularity and heterogeneity 
in expression between different  strains7,8. In extensively studied strains (COL, RN6390, USA300 and Newman), 
the T7SS consists of four integral membrane proteins (EsaA, EssA, EssB and EssC), two cytosolic proteins (EsaB 
and EsaG), five secreted substrates (EsxA, EsxB, EsxC, EsxD and EsaD), and EsaE, which interacts with the T7SS 
substrates to target them to the secretion  apparatus9. A peptidoglycan hydrolase, EssH, was reported to mediate 
T7SS transport across the bacterial cell wall  envelope10.
The molecular architecture of the staphylococcal T7SS has not yet been fully characterized. T7SS integral 
membrane proteins EsaA, EssA, EssB, and EssC are thought to be the core of the T7 secretion machinery, with 
EssC being the central membrane  transporter11–13. Interactions between secreted substrates and co-depend-
ent secretion of substrates have been  demonstrated7,9,14,15. A recent study showed that the functional assembly 
of the T7SS machinery in S. aureus is supported by the flotillin homolog FloA, within functional membrane 
 microdomains16.
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The S. aureus T7SS is pivotal for bacterial virulence. Indeed, S. aureus mutants lacking the entire  T7SS7 or 
specific T7SS components (EsxA, EssB, EssC, EsxC, EsxB, EsaB, EsaD or EsaE) were consistently shown to be 
less virulent and/or persistent in various mouse infection  models11,17–21. EsxA is necessary to delay apoptosis 
of S. aureus-infected epithelial and dendritic cells, while other substrates modulate cytokine  production18,22,23. 
Although the relevance of T7SS to S. aureus is less understood, a role for the toxin-antitoxin pair EsaD (or EssD) 
and EsaG (or EssI) was recently demonstrated in intraspecies  competition9,15.
In the human host, S. aureus encounters fatty acids (FAs) in the blood, on the skin, the nasal mucosa and 
other lipid rich  tissues24–26. Several unsaturated FAs, including palmitoleic acid (C16:1) and linoleic acid (C18:2) 
are known to inhibit S. aureus  growth27,28. In mice, topical or intraperitoneal treatments with such antimicrobial 
FAs or diets rich in antimicrobial FAs decrease bacterial load and increase survival upon S. aureus  infection29,30. 
Many saturated FAs like stearic acid, on the other hand, are non-toxic to this  pathogen31. Irrespective of their 
saturation, host FAs can be incorporated into S. aureus phospholipids via fatty acid phosphorylation by a fatty 
acid kinase (Fak)32. It is thought that this incorporation may contribute to bacterial resistance against toxic host 
 FAs31. Interestingly, S. aureus T7SS expression is induced in response to host-specific  FAs20,21,33. The role of T7SS 
in bacterial resistance to antimicrobial FAs however remains unclear. In this study, we demonstrate that surpris-
ingly, EsxC and other T7SS mutants were more sensitive to unsaturated FAs compared to the wild-type (WT). 
Although there were no differences in binding labelled linoleic acid (LA), LA induced a more leaky membrane 
in the T7SS mutants, and there was less incorporation of LA into EsxC mutant membrane phospholipids. Fur-
thermore, cellular proteomics revealed that in addition to membrane discrepancies, T7SS mutants exhibited 
different redox and metabolic states, which likely resulted in a distinct response to LA.
Results
S. aureus esxC and essC mutants are more sensitive to antimicrobial fatty acids. EsxC, a small 
15-kDa protein secreted by the T7SS, is important for S. aureus persistence in  mice19. However, mechanisms 
underlying EsxC- or T7SS-mediated bacterial survival are not known. In order to understand the role of EsxC, 
we generated an isogenic esxC mutant as described  previously34, and the absence of any secondary site mutations 
was confirmed by whole genome sequencing. ΔesxC had a similar growth rate to the WT USA300 JE2 strain in 
standard rich medium (Supplementary Fig. S1). However, interestingly, when ΔesxC was cultured in the pres-
ence of an unsaturated FA (C18:2), linoleic acid (LA), at a concentration (80 µM) that still allows WT growth, it 
displayed significantly impaired growth, compared to the WT (Fig. 1A,B). ΔesxC did not show a growth defect 
when cultured in parallel in presence of stearic acid (SA), a saturated C18:0 FA (Supplementary Fig. S2A). A 
deletion mutant of the membrane-bound major ATPase EssC (a core T7SS component) also showed a similar 
growth defect in presence of LA but not SA. Both T7SS mutants displayed a decrease in optical density and 
colony forming units (CFU) in presence of LA but not SA (Fig. 1A,C, Supplementary Fig. S2A). Importantly, 
ΔesxC complemented with a plasmid containing the esxC gene reverted to the WT phenotype (Fig. 1D). The 
increased susceptibility of T7SS mutants to antimicrobial fatty acids was not restricted to linoleic acid as when 
cultured in the presence of arachidonic acid, another unsaturated FA (C20:4), growth of ΔesxC and ΔessC was 
inhibited more as compared to the WT (Fig. 1E, F).
T7SS substrates contribute to S. aureus resistance to LA toxicity. Next, we investigated whether 
T7SS proteins other than essC and esxC contributed to S. aureus growth in presence of LA. Mutants lacking 
two other substrates, ΔesxA and ΔesxB, were grown in presence of FAs. Both mutants grew significantly slower 
than the WT USA300 LAC (Fig. 2A,B), in line with previous studies demonstrating the inter-dependency of 
the different T7SS  substrates7,14. To ensure that the increased sensitivity observed for the T7SS mutants was 
not strain specific, RN6390 ΔessC or ΔesxC and Newman ΔesxA or ΔesxB mutants were tested. Similar to the 
USA300 mutants, the growth of all these T7SS mutants was also impacted in the presence of LA (Fig. 2C–F). 
Newman ΔesxA, and RN6390 ΔessC showed significantly decreased growth, while Newman ΔesxB and RN6390 
ΔesxC had a slight growth defect. The growth defect in Newman ΔesxA was abrogated upon complementation 
(Fig. 2G,H). None of the T7SS mutants grew differently compared with WT in presence of stearic acid (Supple-
mentary Fig.S2B–E). Of note, the Newman WT was readily inhibited by a lower concentration of LA (40 µM), 
which is in agreement with the lower T7SS expression levels in this strain compared to  USA3007,14. We conclude 
that a functional T7SS plays a role in S. aureus resistance to LA toxicity.
T7SS is required for maintaining membrane integrity in the presence of LA. To study the mech-
anisms involved in T7SS mediated protection to LA toxicity, further studies were performed using mutants 
constructed in the USA300 JE2 strain lacking EsxC, a representative T7SS effector, or EssC the main T7SS 
transporter. To test if LA-mediated growth inhibition was due to an increased binding of LA to T7SS mutants, 
we chemically engineered LA to produce an azide functionalised LA (N6-diazo-N2-((9Z,12Z)-octadeca-9,12-di-
enoyl)lysine,  N3-LA) or azide-LA (Fig. 3A). After incubating bacteria with azide-LA, click-chemistry with an 
alkyne dye (Click-iT Alexa Fluor 488 sDIBO alkyne) was used to stain azide-LA associated with bacteria. There 
were no obvious differences in the fluorescence from ΔessC and ΔesxC compared to the WT (Fig. 3B), suggesting 
that T7SS components are not involved in binding or sequestering LA.
Unsaturated FAs have been well-documented to disrupt S. aureus  membranes31,35. To study this, bacteria 
treated with azide-LA were also stained with propidium iodide (PI), a good indicator of membrane integrity. 
A more intense PI staining was observed for ΔessC and ΔesxC compared to the WT (Fig. 3C,D). Furthermore, 
to study the effects of unlabelled FA, WT and mutants were stained with PI and SYTO 9 after treatment with 
unlabelled LA. Again, an increased PI staining (Fig. 4A,B) and therefore lower SYTO 9/PI (Live/Dead) ratio 
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was observed for both mutants (Fig. 4C). These data suggest that an intact T7SS helps S. aureus to maintain its 
membrane integrity when faced with the detergent-like effects of unsaturated FAs.
LA-incorporation into membrane phospholipids is modulated by EsxC. When grown in presence 
of unsaturated fatty acids, S. aureus has been shown to incorporate unsaturated FAs into its  membrane31,36. To 
investigate if membrane lipids were altered in the T7SS mutants, lipids from WT USA300 and T7SS mutants 
were analysed by high-performance liquid chromatography (HPLC)-mass spectrometry (MS) in negative ioni-
sation mode. As reported  previously37,38, phosphatidylglycerol (PG) was the major phospholipid present in the 
membrane of WT grown in TSB (Supplementary Fig. S3A). ΔessC and ΔesxC grown with or without 10 µM 
LA (a concentration that has been previously shown to be sub-inhibitory for USA300)21 displayed lipid profiles 
similar to that of WT (Supplementary Fig.  S3A,B). Notably, PG molecular species were significantly altered 
upon growth in LA-supplemented TSB for WT (Fig. 5A), ΔessC (Supplementary Fig. S3C) and ΔesxC (Fig. 5B). 
Figure 1.  Enhanced S. aureus growth inhibition by antimicrobial fatty acids in esxC and essC mutants. (A) S. 
aureus WT USA300, ΔessC, and ΔesxC were grown in TSB or TSB supplemented with 80 µM linoleic (LA). 
Means ± standard error of the mean (SEM) are shown. n = 4. (B) The area under the curve (AUC) of biological 
replicates grown in TSB + LA in (A) were calculated and presented as % relative to the WT. Means ± SEM are 
shown. *Indicates P < 0.05 using a Kruskal–Wallis test with Dunn’s multiple comparisons test. (C) After 14 h 
growth in TSB or TSB supplemented with 80 µM LA or stearic acid (SA), bacteria were serially diluted, and 
CFU were determined. Mean values are presented, and the error bars represent SEM. n = 3, **indicates P < 0.01 
using one-way ANOVA with Dunnett’s test. (D) USA300 WT with the empty pOS1 plasmid (WT pOS1) and 
USA300 JE2 esxC mutant with either pOS1 (ΔesxC pOS1) or pOS1-esxC (ΔesxC pOS1-esxC) were grown in 
TSB or TSB + 80 µM LA as described in (A) followed by CFU estimation. Mean values are shown; error bars 
represent SEM. n = 5, **indicates P < 0.01 using one-way ANOVA with Dunnett’s test. (E) S. aureus WT USA300, 
ΔessC, and ΔesxC were grown in TSB or TSB supplemented with 80 µM arachidonic acid (AA). Means ± SEM 
are shown, n = 3. (F) AUCs of biological replicates grown in TSB + AA in (E) were calculated and presented as % 
relative to the WT. Means ± SEM are shown. *Indicates P < 0.05 using a Kruskal–Wallis test with Dunn’s multiple 
comparisons test.
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Figure 2.  T7SS substrates contribute to resistance to linoleic acid toxicity. (A) S. aureus USA300 wild-type 
(WT) and USA300 esxA (ΔesxA) or esxB (ΔesxB) deletion mutants were grown in TSB or TSB supplemented 
with 80 µM linoleic acid (LA). (B) AUCs of biological replicates grown in TSB + LA as in (A) were calculated 
and presented as % relative to the WT. Means ± SEM are shown. n = 4. (C) S. aureus Newman WT and Newman 
esxA (ΔesxA) or esxB (ΔesxB) deletion mutants were grown in TSB or TSB + 40 µM LA. (D) AUCs of biological 
replicates grown in TSB + LA as in (C) were calculated and presented as % relative to the WT. Means ± SEM 
are shown. n = 4. (E) Growth curves as described in (A) were done with RN6390 wild-type (WT) and RN6390 
essC (ΔessC) or esxC (ΔesxC) deletion mutants. (F) AUCs of biological replicates grown in TSB + LA as in (E) 
were calculated and presented as % relative to the WT. Means ± SEM are shown. n = 3. (G) Newman WT with 
the empty pOS1 plasmid (WT pOS1) and Newman esxA mutant with either pOS1 (ΔesxA pOS1) or pOS1-esxA 
(ΔesxA pesxA) were grown in TSB or TSB + 40 µM LA. Data shown in (A,C,E,G) are representative of at least 
three independent experiments. (H) AUCs of biological replicates grown in TSB + LA as in (G) were calculated 
and presented as % relative to the WT. Means ± SEM are shown. n = 4. In (B,D,F,H) *indicates P < 0.05 using a 
Kruskal–Wallis test with Dunn’s multiple comparisons test.
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Three new LA-specific PG species with mass to charge ratios (m/z) 731 (C33:2), 759 (C35:2), and 787 (C37:2) 
appeared to contain LA (C18:2) or its elongated C20:2 or C22:2 versions, as revealed by their fragmentations 
(Supplementary Fig. S4A–C). PG species containing exogenous, unsaturated FAs were also present in ΔessC and 
ΔesxC. However, LA (C18:2)-containing PG species (C33:2) were less abundant in the esxC mutant compared 
to WT (Fig. 5C). A similar trend, although statistically non-significant (P > 0.05), was observed for C20:2- and 
C22:2-containing PG species (Supplementary Fig. S4D,E), and when all the unsaturated exogenous PG species 
were combined (Fig. 5D). However, there were no significant differences in the incorporation of LA for ΔessC 
compared to WT. A possible explanation is that although ΔessC is defective in the secretion of EsxC, EsxC that 
accumulates in the  cytosol7,10 and membranes (as indicated by our initial studies, Supplementary Fig. S5) of the 
ΔessC mutant, may mediate FA incorporation. Our data suggest that lack of the T7SS component EsxC may 
compromise the elongation and incorporation of LA into S. aureus phospholipids.
T7SS mutations affect the total cellular content and S. aureus responses to LA. In order to gain 
further insight into T7SS-mediated modulation of proteins involved in FA incorporation and membrane home-
ostasis in presence of LA, we used an unbiased proteomic approach to study protein profiles of WT USA300, 
ΔessC, and ΔesxC grown exponentially with or without 10 µM LA. Of note, WT and both these T7SS mutants 
grew similarly in presence of up to 40 µM LA (Supplementary Fig. S6).
Figure 3.  T7SS mutants display increased membrane permeability upon LA binding. (A) Chemical structure 
of azide functionalised linoleic acid (azide-LA; N6-diazo-N2-((9Z,12Z)-octadeca-9,12-dienoyl)lysine,  N3-LA). 
Highlighted in green is the azido lysine. (B) S. aureus USA300 WT, ΔessC, and ΔesxC were grown with shaking 
in TSB to  OD600 of 1.0. Bacteria were then stained for 15 min with 10 µM azide-LA prior to labelling for 1 h with 
alkyne Alexa Fluor 488. Mean percentage of fluorescence values relative to WT (100%) are presented; error bars 
represent SD, n = 5. (C) Micrographs of bacteria grown in TSB and treated as described in (B) and additionally 
stained with propidium iodide (PI). (D) ImageJ was used to quantitate PI fluorescence of bacterial clusters 
from 12 different fields per strain. Each box‐and‐whisker plot depicts the minimal and maximal PI intensities, 
the median is the vertical bar inside the box, which is delimited by the lower and upper quartiles. **Indicates 
P < 0.01 using one-way ANOVA with Dunnett’s test.
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WT vs T7SS mutants in absence of LA treatment. Interestingly, ΔessC or ΔesxC cultured in TSB readily dis-
played proteins with changed abundance when compared to the WT, with 37 and 24 proteins significantly 
(P < 0.05) altered in ΔessC and ΔesxC, respectively. Similarly, 14 proteins were differentially abundant in both 
ΔessC and ΔesxC (Fig. 6A,B). These included proteins associated with signal transduction (LytR and ArlR), the 
CW (acetyltransferase GNAT, FnbB and MazF), DNA repair (MutL and RadA), nucleotide binding (ATP-grasp 
domain protein and YqeH), hydrolysis (amidohydrolase), cell stress response [universal stress protein (Usp) 
family], or were uncharacterised (A0A0H2XGJ8, YbbR and lipoprotein) (Fig. 6B, Table 1). Of the 33 proteins 
changed only in ΔessC (23 proteins) or ΔesxC (10 proteins), nearly 40% (13 proteins) were associated with oxida-
tion–reduction and other metabolic processes. Ten proteins which were annotated or reported to be membrane 
proteins, were more abundant in ΔessC (Table 1), which included SrrB, a membrane protein that is activated by 
impaired  respiration39, and whose gene expression increased 6 times upon growth in presence of  LA21. SrrB was 
also detected at higher levels in the esxC mutant although the increase was non-significant (P = 0.07).
Figure 4.  T7SS mutants display increased PI staining when treated with LA. Live/Dead staining of S. aureus 
USA300 WT, ΔessC or ΔesxC mutants after growth to  OD600 of 1.0, without (A) or with treatment with 
80 µM (B) linoleic acid. Images are representative of 3 independent experiments. (C) The ratio of SYTO 9: PI 
fluorescence (live:dead cells) of 25 different fields per strain was quantitated with ImageJ. Means ± SD are shown, 
n = 3; ***Indicates P < 0.001, **Indicates P < 0.01 using a one-way ANOVA with Tukey’s multiple-comparison 
test.
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WT vs T7SS mutants in presence of LA. We then compared the proteomic profiles of LA-treated strains (WT, 
ΔessC or ΔesxC) with their untreated counterparts. Clearly, the principal component analysis revealed that the 
differences due to the genetic makeup (WT or T7SS mutants) were less prominent than the dramatic changes 
induced by LA (Supplementary Fig. S7). These changes are exemplified for the WT; 163/1,132 proteins identified 
had an altered relative abundance upon growth with LA (Fig. 6C). 167 and 171 proteins were changed (P < 0.05) 
in ΔessC and ΔesxC, respectively, in response to LA, of which ~ 40% (68 proteins) were common to these mutants 
and their WT (Fig. 6D). At least 30% of proteins that were significantly different (P < 0.05) were unique to WT 
(53 proteins), ΔessC (50 proteins), or ΔesxC (64 proteins) (Fig. 6D), suggesting that each strain responds differ-
ently to LA. However, almost all proteins (13/14 proteins) that were similarly deregulated in ΔessC and ΔesxC 
Figure 5.  The esxC mutant is less able to incorporate LA into its phospholipids. Representative HPLC 
chromatograms of native phosphatidylglycerol (PG) species of S. aureus USA300 JE2 WT (A) or ΔesxC (B) 
grown in TSB (top panel) or in TSB supplemented with 10 µM LA (bottom panel), in negative ionisation mode. 
Relative quantification of the indicated PG species containing an unsaturated FA in LA-treated WT, ΔessC and 
ΔesxC. The C18:2-containing PG species, C33:2 (C) and total unsaturated fatty acid (C18:2, C20:2 and C22:2) 
containing exogenous PG species (C33:2, C35:2 and C37:2) (D) are presented as ratios of total PG species. Mean 
values are shown; error bars represent SD. n = 3, *indicates P < 0.05 using one-way ANOVA with Dunnett’s test.
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grown without LA (Fig. 6B) were modulated in presence of LA (highlighted in bold in Dataset S1). Proteins that 
were less abundant in both mutants were, upon LA treatment, either increased to WT levels (MutL, acetyltrans-
ferase GNAT, Toxin MazF, and ATP-grasp domain protein), or were unchanged in the mutants and decreased 
in the LA-treated WT (LytR and FnbB) (Dataset S1). Likewise, proteins with increased abundance in ΔessC 
or ΔesxC were: (i) downregulated to WT levels (putative lipoprotein A0A0H2XGW7), (ii) unaltered in both 
mutants and upregulated in WT (Usp, amidohydrolase, and YbbR), (iii) or further increased in the essC mutant 
and strongly upregulated in WT (A0A0H2XGJ8) (Dataset S1). In sum, except for ArlR and RadA that were 
inversely regulated in all strains upon LA treatment, proteins similarly deregulated in ΔesxC and ΔessC were 
further modulated in response to LA, indicating that proteins altered by the lack of T7SS are important in the 
staphylococcal response to unsaturated fatty acids like LA.
Altered molecular functions in presence of LA. We then used QuickGO (a web-based tool for Gene Ontology 
searching)40 to retrieve GO terms associated with the ten most significantly upregulated proteins in LA-treated 
WT (Dataset S1). Strikingly, 9/10 proteins had a hydrolase or an oxidoreductase activity. A comprehensive, sta-
tistical analysis showed a clear enrichment of 8 specific molecular functions (P < 0.05) in at least one strain (WT 
or T7SS mutants) (Fig. 7A). Oxidoreductase and hydrolase activities were enhanced in LA-treated WT, while 
ΔessC and ΔesxC were less able to upregulate proteins with these molecular functions. Flavin adenine dinucleo-
tide (FAD)-binding, which plays a role in oxidation–reduction and FA metabolic processes, was similarly more 
enriched in the LA-treated WT. In contrast, transferase activity, which is linked to CW synthesis, was induced 
more in T7SS mutants compared to the WT. Molecular functions that are decreased upon LA challenge were also 
determined (Fig. 7B). In agreement with reduced intracellular ATP levels following membrane damage by anti-
microbial  FAs35, genes with the ATP-binding function (mainly ATP-binding ABC transporters) were negatively 
impacted in the WT. ATP-dependent lyases were also repressed in the WT. On the contrary, T7SS mutants were 
less able to modulate ATP-binding proteins. Instead, a strong inhibition of ribosomal constituents and other 
translation-related components was seen (Fig. 7B).
To test the oxidoreductive states of the WT and the mutants, we stained bacteria with dichlorofluorescin 
(DCF), which detects reactive oxygen  species41. Reflecting the changes seen in the proteomics data, when treated 
with 10 µM LA there is an increase in the ROS generated in the T7SS mutants compared to the WT (Fig. 7C). 
However, in bacteria grown without LA, the mutants have slightly less or no change in the ROS generated 
compared to WT (Fig. 7D). Taken together, our proteomic analyses reveal that the lack of T7SS induces altered 
Figure 6.  Quantitative proteomics shows altered cellular content and bacterial response to LA in T7SS mutants. 
S. aureus USA300 WT and mutants (ΔessC and ΔesxC) were grown in TSB or TSB supplemented with LA. (A) 
Venn diagram showing the number of proteins with altered abundance compared to WT specific to ΔessC (23) 
or ΔesxC (10), and common to ΔessC and ΔesxC (14). (B) The 14 proteins that are similarly changed in ΔessC 
and ΔesxC mutants are highlighted on a volcano plot. (C) Volcano plot showing the extensive change in the 
LA-treated WT compared to WT. (D) Venn diagram displaying the numbers of proteins with altered relative 
abundance upon LA challenge of WT (LA.WT), ΔessC (LA.dEssC) or ΔesxC (LA.dEsxC) compared to the 
respective untreated samples.
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membrane and metabolic states indicative of oxidative stress responses. While multiple pathways are modulated 
in the WT to mitigate LA-induced damage on the bacterial membrane, such responses are clearly altered in the 
absence of the T7SS.
Table 1.  Proteins with changed abundance in ΔessC and ΔesxC mutants relative to the WT USA300 JE2.
Functions Uniprot ID
ΔessC/WT ΔesxC/WT
DescriptionLog2 FC Adjusted P value Log2 FC Adjusted P value
Signal transduction systems
Q2FK09  − 3.0 4.90E−13  − 3.1 4.90E−13 Sensory transduction protein LytR
Q2FH23  − 2.9 0.002527  − 2.1 0.026184 Response regulator ArlR
Membrane proteins
A0A0H2XF42 3.0 1.75E−10 0 1 Cytochrome D ubiquinol oxidase, subunit I
A0A0H2XDZ5 1.7 1.68E−05 0 1 Uncharacterized membrane protein
A0A0H2XFJ8 2.0 0.001077 0.5 0.883953 Uracil permease
A0A0H2XGW7 2.7 0.005757 2.5 0.010784 Putative lipoprotein
A0A0H2XIA9 1.0 0.006115 0 1 Protein translocase subunit SecY
Q2FIN2 1.6 0.029451 0.5 0.970614 Prolipoprotein diacylglyceryl transferase LGT
A0A0H2XKD9 2.0 0.038093 1.8 0.070347 Staphylococcal respiratory response protein SrrB
A0A0H2XFE1 3.4 0.039814 1.1 0.970614 Peptidase
A0A0H2XJV8 2.0 0.04444 1.5 0.231285 Cyclic-di-AMP phosphodiesterase
A0A0H2XGF4 3.0 0.044681 0.9 0.986458 Sodium:dicarboxylate symporter family protein
A0A0H2XHV2 2.5 0.049168 2.4 0.070182 Glycine betaine transporter OpuD
Stress response
A0A0H2XKH6 2.2 5.80E−05 2.5 1.07E−05 Universal stress protein family
A0A0H2XIZ0 0.0 1  − 3.4 1. 06E−10 OsmC/Ohr family protein
DNA repair
Q2FHE2  − 2.3 1.79E−08  − 2.3 1.19E-08 DNA mismatch repair protein MutL
A0A0H2XI63  − 2.0 0.004036  − 2.0 0.004036 DNA repair protein RadA
A0A0H2XHT1  − 0.3 0.708343  − 1.9 0.008379 Formamidopyrimidine-DNA glycosylase MutM
Oxidation–reduction process
A0A0H2XJ90 1.1 0.038093 1.0 0.088334 D-isomer specific 2-hydroxyacid dehydrogenase family protein
A0A0H2XHE0 2.4 0.039099  − 0.1 1 Thiol-disulphide oxidoreductase, DCC family protein
A0A0H2XGR9 0.0 1 1.4 8.89E-08 Oxidoreductase, Gfo/Idh/MocA family
A0A0H2XK08 1.0 0.406975 2.9 0.00791 Oxidoreductase, short chain dehydrogenase/reductase family
A0A0H2XFZ3  − 0.8 0.404225 2.1 0.016405 Nitroreductase family protein
Hydrolases
A0A0H2XE49 2.9 1.07E−06 2.9 5.99E−07 Amidohydrolase
Q2FES9  − 2.7 0.003385  − 0.3 1 Uncharacterized hydrolase
A0A0H2XFF2  − 0.8 0.016697  − 0.5 0.157809 Peptidase, U32 family
A0A0H2XJH8 0.0 1 2.8 1.06E−10 Peptidase M20 domain-containing protein 2
A0A0H2XJ54 0.0 1 2.0 0.000949 Hydrolase (HAD superfamily)
Q2FEG2  − 0.2 0.854748  − 2.9 0.004615 Formimidoylglutamase
Metabolism
A0A0H2XGU2  − 1.6 4.99E−06  − 0.1 1 Pseudouridine synthase
A0A0H2XK15 2.8 0.004424 0.9 0.777138 1-phosphatidylinositol phosphodiesterase
Q2FEK2  − 1.6 0.038093  − 0.3 1 Urease accessory protein UreE
Q2FI05 1.1 0.038093 0.0 1 Bifunctional purine biosynthesis protein PurH
Q2FIL2 2.9 0.038093 0.8 0.970614 SsrA-binding protein
A0A0H2XII6 1.8 0.038093 1.5 0.088334 Orn/Lys/Arg decarboxylase
A0A0H2XJR8  − 0.9 0.04444  − 0.5 0.61246 RNA methyltransferase, RsmD family
A0A0H2XKG7 0.0 1 1.4 8.18E−08 Aspartokinase
Cell wall composition
A0A0H2XJQ4  − 4.0 4.92E−11  − 4.0 3.28E−11 Acetyltransferase, GNAT family
A0A0H2XKG3  − 2.3 0.001238  − 1.7 0.016405 Fibronectin binding protein B
A0A0H2XJC8  − 2.3 0.009779  − 3.0 0.000819 Phi77 ORF017-like protein (Toxin MazF)
Q2FE03 0.0 1 2.6 1.18E−12 Fibronectin-binding protein A
Nucleotide binding
A0A0H2XHY5  − 2.3 8.58E−06  − 2.3 6.01E−06 ATP-grasp domain protein
A0A0H2XFA5 3.3 0.014259 3.5 0.008379 Putative GTP-binding YqeH protein
Uncharacterised proteins
A0A0H2XGJ8 2.2 0.000372 2.4 9.41E−05 Uncharacterized protein
A0A0H2XE09 2.1 0.008231 1.9 0.016405 Ybbr-like uncharacterized protein
Q2FFI4 3.4 0.020136 0.9 0.970614 UPF0316 membrane protein
A0A0H2XG24 1.1 0.022345 0.8 0.088334 Uncharacterized protein
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Discussion
Host fatty acids (FAs) play a crucial role in the host defence to S. aureus infections. S. aureus is particularly 
sensitive to unsaturated FAs, which are abundant in the human  skin27,29,31,33,42. We report here that the T7SS, an 
important component of S. aureus virulence arsenal, is critical in modulating the response to antimicrobial host 
FAs by maintaining the bacterial cell membrane integrity. A functional T7SS enables bacteria to mitigate LA-
induced toxicity and grow better than mutants with a compromised T7SS. In the absence of T7SS components, 
Figure 7.  An altered oxidoreductive response in T7SS mutants in response to LA. Heatmaps depicting the P 
values of enriched (A) or diminished (B) molecular functions following a gene set analysis based on GO (gene 
ontology) annotations. Molecular functions that are changed in at least one strain (P < 0.05) following growth 
in presence of LA are shown. The shades of blue (A) or red (B) correspond to –  log10 (P value). ROS levels were 
measured in cultures of S. aureus USA300 JE2 WT, ΔessC or ΔesxC grown to  OD600 of 1.0 treated (C) with 
or without LA (D) using DCF reagent. Means ± SD are shown N = 5. *Indicates P < 0.05, **indicates P < 0.01, 
***indicates P < 0.001 using the Kruskal–Wallis rank test.
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LA is less incorporated into membrane phospholipids and enhances cell membrane damage. Furthermore, these 
bacteria are unable to activate adaptive mechanisms involved in LA resistance, as indicated by cellular proteomics.
T7SS loci in S. aureus vary in the organisation of four modules and their transcription across different strains. 
In this study, a protective role for the T7SS against FA toxicity was clear for S. aureus strains USA300, Newman, 
RN3690, which have a modular organisation representative of  NCTC83258. However, we see a variation in the 
degree of inhibition by LA with certain substrates and strains (Newman ΔesxB and RN6390 ΔesxC), which may 
be due to differences in T7SS expression and regulation between  strains7,14. It is noteworthy that strains with other 
T7SS modular configurations have been reported to activate T7SS in response to LA (MRSA252)33 or require 
a functional T7SS for infection of FA-rich mouse skin (ST398)43,44. Hence, although T7SS substrates in many 
staphylococcal strains are yet to be characterised, it is plausible that the protective role of T7SS against toxic 
FA is conserved in strains with different T7SS. Additionally, several studies on the USA300 T7SS have shown 
multiple interactions between staphylococcal T7SS components, although the precise molecular architecture of 
this system remains unclear. EsxC (previously EsaC) was first described as a secreted  protein19. However, it has 
been subsequently shown to localize within staphylococcal  membranes7,10. Based on the available data, EsxC is 
likely to be associated to EsxA, EsaD, or EsaE on the  membrane9,14,18.
The cellular proteomics data reveal that the abundance of more proteins is altered in ΔessC (37) than esxC 
(24) in comparison to S. aureus WT, which is in keeping with the greater importance of EssC as the conserved 
driving force of the  T7SS8. Importantly, almost 60% of proteins deregulated in ΔesxC are similarly affected in 
ΔessC, strongly suggesting that any modification of the T7SS core leads to a similar staphylococcal response. 
Surprisingly, proteins with altered abundance in USA300 ΔessC were distinct to the ferric uptake regulator 
(Fur)-controlled genes differentially expressed in RN6390 ΔessC45. This discrepancy might be due to strain dif-
ferences, including rsbU defect in RN6390 that impairs SigB  activity46,47. Nevertheless, given the known role of 
Fur in oxidative stress  resistance48,49, both mutants may display an altered oxidative status following essC dele-
tion. S aureus RN6390 also differentially expresses redox-sensitive genes in absence of  EsaB50. Also, since the 
T7SS substrate EsxA is upregulated in response to hydrogen  pyroxide45, one could speculate that lack of T7SS 
stimulates an oxidative stress response. A further indication of altered physiological states of ΔessC and ΔesxC 
was the decreased abundance of the two-component regulatory system proteins, LytSR, ArlSR and SrrAB, which 
was consistent with down-regulation of lytR transcription observed previously in the absence of arlR51. Impor-
tantly, the S. aureus response to antimicrobial FAs includes downregulation of lytRS33,52, and upregulation of 
srrB21. Given that LytSR is involved in bacterial surface and membrane potential  modulation53,54, T7SS defects 
are likely to result in an altered cell envelope.
It is striking that the staphylococcal T7SS is strongly upregulated in presence of sub-inhibitory concentrations 
of  LA21,33. FAs with more cis double bonds, which are more toxic toward S. aureus31, are also more potent T7SS 
 activators21. Our current study interestingly suggests a protective role of T7SS against LA toxicity. Previously 
described S. aureus antimicrobial FA resistance mechanisms, including IsdA or wall teichoic acid-mediated 
modulation of cellular  hydrophobicity29,31,55,56, and FA detoxification with the efflux pumps Tet38 and  FarE57,58, 
do not appear to explain the increased susceptibility of T7SS mutants to LA, as indicated by cellular proteomics. 
In line with a role for T7SS in the oxidative stress response, T7SS mutants were less able to prime their redox-
active proteins in response to LA-induced oxidative stress. Instead, to cope with LA, they appear to rely on strong 
inhibition of the protein synthesis machinery, which is reminiscent of the stringent  response59.
FA can inhibit S. aureus growth by destabilising the cell membrane through several mechanisms includ-
ing membrane  permeabilisation31. However, both toxic and non-toxic FA can be incorporated into bacterial 
 phospholipids31,60, and reduced incorporation at inhibitory concentrations correlated with an accumulation of 
free  FAs31,36. The incorporation of exogenous FA into membrane phospholipids occurs via a two-component 
fatty acid kinase (Fak)31,32,60, which was reported to be important for T7SS activation by unsaturated  FA21. FakB1 
and FakB2, bind to FAs, and FakB-bound FAs are phosphorylated by FakA prior to their  incorporation32. Our 
lipidomic analyses revealed that in the absence of EsxC, bacteria were less able to incorporate LA into their 
phospholipids (Fig. 5), and displayed an increased membrane permeability in presence of LA. However, as 
all the T7SS mutants showed increased sensitivity to FA, it seems counterintuitive that LA incorporation was 
impacted more in ΔesxC than in ΔessC given the central role of EssC in T7  secretion11–13. In the incorporation 
experiments which were performed in presence of low non-inhibitory LA concentration (10 µM), it is possible 
that EsxC that accumulates in the membrane (Supplementary Fig. S5) in the absence of protein secretion by 
EssC, mediates LA incorporation in the essC mutant. In higher concentrations of LA, however, any T7SS defects 
may affect incorporation and hence sensitivity to unsaturated FA. It is also worth noting that transcript levels of 
esxC, and not essC, were strongly upregulated in a S. aureus fakA  mutant32, Proteomic analyses however showed 
that protein levels of Fak proteins in the T7SS mutants remained unaltered in presence or absence of LA, sug-
gesting no T7SS-mediated regulatory control of the Fak pathway. Although we currently do not understand the 
precise mechanisms involved in T7SS-mediated protection, we speculate that EsxC and other interdependent 
T7SS substrates may play a role in facilitating Fak function in S. aureus membranes, either by mediating recruit-
ment or targeting of Fak proteins to the membrane. Further investigations are necessary to clarify the molecular 
mechanisms underlying T7SS-mediated FA incorporation within staphylococcal membranes.
The increased susceptibility of T7SS mutants to LA might explain why they are less virulent in environments 
rich in LA and other antimicrobial FAs, like the mouse lungs (ΔessC)20, abscesses (ΔesxC and ΔesaB), liver and 
skin (ΔessB)21,44. Previous research showing T7SS induction by host-derived FAs further supports the importance 
of T7SS in such  environments20,21. Taken together, we conclude that T7SS plays a key role in modulating the 
S. aureus cell membrane in response to toxic host FAs. Although at present, it is unclear how T7SS contributes 
to staphylococcal membrane architecture, T7SS interaction with the flotillin homolog FloA within functional 
membrane  microdomains16 corroborates the idea that T7SS proteins interact with many other proteins to modu-
late S. aureus membranes. Indeed, our data also suggest that blocking T7SS activity would make S. aureus more 
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vulnerable to antimicrobial FAs, a key anti-staphylococcal host defence, thus making T7SS a very attractive 
drug target.
Materials and methods
Bacterial strains and growth conditions. The plasmid cured USA300 LAC JE2 strain and its mutants 
(ΔessC and ΔesxC) were used for most parts of the study. All S. aureus strains used are listed in Table S1, and 
were grown aerobically in tryptic soy broth (TSB) overnight (O/N) at 37ºC for each experiment unless stated 
otherwise. For complemented S. aureus strains, TSB was supplemented with 10 µg/mL chloramphenicol.
construction of bacterial mutants. The primers used are listed in Table S2. In-frame deletion of essC or 
esxC was performed as described  previously34. Briefly, 1-kb DNA fragments up and downstream of the targeted 
gene sequence were PCR-amplified from USA300 LAC JE2 chromosomal DNA, and both PCR products fused 
via SOEing (splicing by overlap extension)-PCR. The 2-kb DNA fragment obtained was cloned into pKOR1, 
and used for in-frame deletion. Putative mutants were screened by PCR-amplification of a fragment including 
the gene of interest, whose deletion was confirmed by Sanger sequencing. Further, to confirm that successful 
mutants did not have any additional mutations, lllumina whole genome sequencing was performed on libraries 
prepared with the Nextera XT kit and an Illumina MiSeq instrument following manufacturers’ recommenda-
tions. For complementation, full-length esxC gene was cloned onto pOS1CK described  previously23.
Growth curves. O/N bacterial cultures were diluted to an  OD600 of 0.05 in plain TSB or TSB supplemented 
with fatty acids. Bacteria were then grown in a 96-well plate with shaking, and the  OD600 was measured every 
15 min with a FLUOstar OMEGA plate reader (BMG Labtech, UK). Areas under the curves were computed with 
GraphPad Prism 8.0.
Synthesis of azide functionalized linoleic acid. A 2-step synthesis was used to obtain N6-diazo-
N2-((9Z,12Z)-octadeca-9,12-dienoyl)lysine,  N3-LA (azide-LA). LA was first functionalized with N-hydroxy-
succinimide (NHS) in anhydrous dimethyl formamide (DMF) in presence of N-(3-dimethylaminopropyl)-N’-
ethylcarbodiimide hydrochloride. The solvent was then removed and replaced by dicholoromethane (DCM), 
following which the reaction mixture was washed with water and dried over magnesium sulphate. The product, 
2,5-dioxopyrrolidin-1-yl (9Z,12Z)-octadeca-9,12-dienoate (NHS-LA), was analysed using 1H nuclear magnetic 
resonance (NMR) spectroscopy (Supplementary Fig. S8A) and mass spectrometry (MS). MS: [M + Na]+ 400.5 
(calculated), 400.5 (found).
NHS-LA was left O/N at room temperature (RT) to react with l-azidolysine hydrochloride in anhydrous 
DMF, and produce azide-LA. 
DMF was then removed, the reaction mixture precipitated in water, and dried under vacuum to obtain a clear 
oil. The composition of the oil was confirmed as being a mixture of azide-LA and unmodified LA (20% and 80%, 
respectively) based on 1H NMR (Supplementary Fig. S8B) and MS data. MS: [LA-H]− 279.5 (calculated), 279.2 
(found), [M-H]− 433.3 (calculated), 433.6 (found).
Binding assays with azide-LA and click chemistry. S. aureus USA300 JE2 WT, ΔessC, and ΔesxC, 
grown to  OD600 of 1.0, were treated with 10 µM azide-LA for 15 min at 37 °C with shaking. The samples were 
then centrifuged, and the bacterial pellets resuspended in PBS supplemented with 4  µg/mL Click-iT Alexa 
Fluor 488 sDIBO alkyne (Life Technologies LTD, UK). After incubation at 25 °C for 1 h with shaking, bacteria 
were washed with PBS, and binding to azide-LA was quantified by measuring fluorescence using a FLUOstar 
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OMEGA plate reader (BMG Labtech, UK). The samples imaged with a microscope were additionally stained 
with 3 µM propidium iodide, following click chemistry. Bacteria stained with Click-iT Alexa Fluor 488 sDIBO 
alkyne and 3 µM propidium iodide were immobilized on agarose-covered glass slides, and viewed with a Leica 
DMi8 widefield microscope (Leica Microsystems LTD, UK). Images were analysed with the ImageJ processing 
package  Fiji61.
Live/dead staining. Bacteria grown to  OD600 of 1.0, were treated with 80 μM linoleic acid for 15 min at 
37 °C with shaking. The samples were then centrifuged, and the bacterial pellets resuspended in PBS and sup-
plemented with a 1:1 ratio of 2X LIVE/DEAD solution (6 μM SYTO-9 stain and 30 μM propidium iodide) from 
LIVE/DEAD BacLight kit (Invitrogen). After incubation in the dark for 15 min, bacteria were washed with PBS, 
spotted on to agarose pads and imaged using a Leica DMi8 widefield microscope (Leica Microsystems, UK). 
Acquired images were analysed with the ImageJ processing package, Fiji.
Lipid extraction and analyses. Lipids were extracted from bacterial cultures as described  elsewhere62. 
Briefly, bacteria were grown to  OD600 of 1.0 in TSB or TSB supplemented with 10 µM LA, centrifuged in a 2 mL 
glass Chromacol vial (Thermo Scientific), and resuspended in 0.5  mL MS grade methanol (Sigma-Aldrich). 
MS grade chloroform was then used to extract lipids. The extracted lipids were dried under nitrogen gas with 
a Techne sample concentrator (Staffordshire, UK), and the lipid pellets resuspended in 1 mL acetonitrile. The 
samples were then analysed by LC–MS with a Dionex 3400RS HPLC coupled to an amaZon SL quadrupole ion 
trap mass spectrometer (Bruker Scientific) via an electrospray ionisation interface. Both positive and negative 
ionisation modes were used for sample analyses. The Bruker Compass software package was utilized for data 
analyses, using DataAnalysis for peak identification and characterization of lipid class, and QuantAnalysis for 
quantification of the relative abundance of distinct PG species to total PG species.
cellular proteomics. S. aureus strains were grown O/N at 37ºC on tryptic soy agar plates. The next day, 
single colonies were used to inoculate 10 mL plain TSB or TSB with 10 µM LA. Cultures were grown at 37ºC with 
180-rpm shaking until an  OD600 of 3.2 ± 0.2 was reached. The bacteria were then centrifuged, washed with PBS, 
and resuspended in lysis buffer (PBS, 250 mM sucrose, 1 mM EDTA, and 50 µg/mL lysostaphin) supplemented 
with cOmplete, mini EDTA-free protease inhibitor cocktail (Sigma-Aldrich, UK). After 15 min incubation at 
37 °C, cells were lysed mechanically with silica spheres (Lysing Matrix B, Fischer Scientific, UK) in a fast-prep 
shaker as described  previously16. Samples were then centrifuged, and the supernatants transferred to fresh tubes, 
where proteins were reduced and alkylated for 20 min at 70 °C with 10 mM TCEP (tris(2-carboxyethyl)phos-
phine) and 40 mM CAA (2-chloroacetamide), respectively. Next, the solvent was exchanged first to 8 M urea 
buffer then to 50 mM ammonium bicarbonate (ABC). Proteins were digested O/N at 37 °C with mass spectrom-
etry grade lysyl endopeptidase LysC and sequencing grade modified trypsin (Promega LTD, UK).
Label-free protein quantification. Peptides prepared for proteome analyses were desalted and concen-
trated with a C18 cartridge in 40 µL MS buffer (2% acetonitrile plus 0.1% trifluoroacetic acid). For each sam-
ple, 20 µL were analysed by nanoLC-ESI–MS/MS using the Ultimate 3000/Orbitrap Fusion instrumentation 
(Thermo Scientific), and a 90-min LC separation on a 50 cm column. The data were used to interrogate the 
Uniprot Staphylococcus aureus USA300 database UP000001939, and the common contaminant database from 
 MaxQuant63. MaxQuant software was used for protein identification and quantification using default settings. 
Intensities were  log2-tansformed with the Perseus software, and proteins with one or no valid value for every 
sample in triplicate were filtered. Missing values in cellular proteomics data were imputed on R. Specifically, for 
each sample, the imputed value was either the lowest intensity across all samples if at least two biological repli-
cates had missing values or the average of two valid values if only one was missing.
immunoblotting. 15 µg of proteins per sample (cell membrane and cell wall fractions) were loaded onto 
Mini-Protean TGX precast protein gels (Bio-Rad). After electrophoresis, proteins were transferred to PVDF 
membranes, which were cut and probed in parallel with anti-EsxC7 and anti-PBP2a64 antibodies.
Statistical analyses. Except for the proteomics results, the statistical tests were performed with GraphPad 
Prism 8.0 as indicated in the Figure legends, with P values < 0.05 considered significant. A paired two-tailed 
Student’s t-test or a paired Mann–Whitney U test was used for pairwise comparisons. An ordinary one-way 
analysis of variance (ANOVA) with Dunnett’s multiple comparisons test or a Kruskal–Wallis test with Dunn’s 
multiple comparisons test was applied to data form three or more groups. The fold changes and P values of the 
proteomics data were calculated with the R package  limma66, with USA300 JE2 WT or bacteria grown without 
LA as references.
Data availability
The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the 
 PRIDE65 partner repository with the dataset identifier PXD013081 and 10.6019/PXD013081. Cellular proteomic 
samples are labelled MS18-193.
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